LAX.SH
ICICI PRU LIFE INS CO LTD·LIFE INSURANCE 29.83·Insurance Companies
Price
490.7
+2.21%52W Range
Market Cap
₹71,186.69 Cr
Traded: ₹27.96 Cr (0.04%) 0.0x
Free Float: ₹2,306.45 Cr (1.21% of FF traded)
Volume · 60D trend
5.72 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +12.0% | +9.0% | +9.0% | -- | -- | Stable |
| Return | -- | +4.0% | +8.0% | -1.0% | -- | Stable |
| Sales | +12.0% | -5.0% | +8.0% | -- | -10.0% | Stable |
| Profit | +0.0% | +11.0% | +26.0% | -- | +34.0% | Accelerating |
Quarterly Results
Mar 2026
14 AprDec 2025
13 JanSep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,185 | 22,834 | 11,936 | 25,401 | 15,687 | 4,536 | 25,158 | 25,396 | 22,482 | 26,430 | 17,388 | 23,384 | 10,984 | 17,426 |
| Expenses | 3,940 | 22,093 | 11,955 | 25,188 | 15,272 | 4,295 | 24,839 | 25,362 | 22,760 | 26,584 | 17,682 | 23,663 | 11,400 | 17,502 |
| Operating Profit | -754 | 741 | -19 | 213 | 415 | 241 | 319 | 34 | -278 | -155 | -293 | -280 | -416 | -76 |
| OPM % | -24.0% | 3.0% | 0.0% | 1.0% | 3.0% | 5.0% | 1.0% | 0.0% | -1.0% | -1.0% | -2.0% | -1.0% | -4.0% | 0.0% |
| Other Income | 1,036 | -243 | 408 | 177 | 183 | 169 | -17 | 237 | 549 | 420 | 570 | 496 | 780 | 352 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 281 | 498 | 389 | 390 | 598 | 410 | 302 | 271 | 270 | 265 | 276 | 216 | 364 | 277 |
| Tax % | -122.0% | 22.0% | 24.0% | 23.0% | 36.0% | 21.0% | 17.0% | 17.0% | 36.0% | 14.0% | 12.0% | 5.0% | 35.0% | 20.0% |
| Net Profit | 624 | 387 | 296 | 301 | 385 | 325 | 251 | 224 | 174 | 227 | 244 | 206 | 235 | 222 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 4.3 | 2.7 | 2.0 | 2.1 | 2.7 | 2.3 | 1.7 | 1.6 | 1.2 | 1.6 | 1.7 | 1.4 | 1.6 | 1.5 |
| Sales Growth (YoY) | -79.7% | 403.4% | -52.6% | 0.0% | -30.2% | -82.8% | 44.7% | 8.6% | 104.7% | 51.7% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -86.0% | 91.3% | -53.0% | 61.9% | 245.8% | -82.0% | -0.9% | 13.0% | -14.9% | 52.0% | -25.6% | 112.9% | -37.0% | -- |
| OP Growth (YoY) | -281.7% | 207.5% | -106.0% | 526.5% | 249.3% | 255.5% | 208.9% | 112.1% | 33.2% | -103.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | -201.8% | 4000.0% | -108.9% | -48.7% | 72.2% | -24.5% | 838.2% | 112.2% | -79.4% | 47.1% | -4.6% | 32.7% | -447.4% | -- |
| Profit Growth (YoY) | 62.0% | 19.0% | 18.0% | 34.0% | 122.0% | 43.0% | 3.0% | 9.0% | -26.0% | 2.0% | 22.0% | 32.0% | 26.0% | -29.0% |
| EPS Growth (YoY) | 61.0% | 18.7% | 17.2% | 33.3% | 120.7% | 42.4% | 3.0% | 9.1% | -26.2% | 2.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 61.0% | 30.9% | -1.9% | -22.1% | 18.7% | 29.3% | 11.5% | 28.9% | -23.4% | -6.5% | 18.2% | -12.8% | 6.5% | -- |
| OP Margin | -23.7% | 3.3% | -0.2% | 0.8% | 2.6% | 5.3% | 1.3% | 0.1% | -1.2% | -0.6% | -1.7% | -1.2% | -3.8% | -0.4% |
| Net Margin | 19.6% | 1.7% | 2.5% | 1.2% | 2.5% | 7.2% | 1.0% | 0.9% | 0.8% | 0.9% | 1.4% | 0.9% | 2.1% | 1.3% |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | 14.8% | 2.0% | 3.9% | 1.9% | 2.6% | 10.5% | 2.0% | 1.9% | 2.0% | 1.4% | 2.3% | 1.8% | 3.5% | 2.1% |
| P/S | 1.12 | 1.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 44.25 | 57.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 5.22 | 6.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Investor Presentation for the month of June 2026.
The Company has allotted 11,360 equity shares on July 7, 2026 under Employees Stock Option Scheme and Employees Stock Unit Scheme.
Please find enclosed intimation for resignation of Director of the Company.
Please find enclosed Outcome of Board Meeting.
Please find enclosed the intimation for resignation of director of the Company.
Please find attached intimation on disclosure under Regulation 30, 30A and 51 of SEBI LODR Regulations.
Please find enclosed schedule of earnings conference call for Q1-FY2027
As per attached
Please find attached the proceedings of the AGM held on June 30, 2026.
Please find attached the proceedings of the Annual General Meeting along with Scrutinizer''s Report held on June 30, 2026
Closure of Trading window
ICICI Prudential Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 ,inter alia, to consider and approve the ....
The company has allotted 67604 Equity Shares on June 23, 2026 under Employee Stock Option Scheme and Employee Stock Unit Scheme.
The company has allotted 47,658 Equity Shares on June 16, 2026 under the Employees Stock Option Scheme and Employees Stock Unit Scheme.
Investor presentation for the month of May 2026.
The Company has allotted 35,610 equity shares under the Employees Stock Unit Scheme (2023).
Please find attached Business Responsibility and Sustainability Report for FY2026.
Please find attached the Annual Report of the Company for FY2026
Please find attached notice of 26th AGM and Integrated Annual Report for FY2026.
Disclosure under Regulation 30 and 51 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Company has allotted 109,034 Equity Shares under the Employees Stock Option Scheme (2005) and the Employee Stock Unit Scheme (2023).
Please find attached Annual Secretarial Compliance Report for the financial year ended March 31, 2026.
Please find enclosed the schedule of meeting with analyst/investor to be held on June 9, 2026.
Please find enclosed the schedule of meeting with analyst/investor to be held on June 4, 2026.
Please find enclosed the schedule of meeting with analyst/investor to be held on June 8, 2026.
Please find enclosed the schedule of meeting with analyst/investor to be held on June 3, 2026.
Intimation Under Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The Company has allotted 63,019 equity shares under the Employees Stock Option Scheme (2005) and the Employees Stock Unit Scheme (2023).
The Company has allotted 29,301 equity shares under the Employees Stock Option Scheme (2005) and the Employees Stock Unit Scheme (2023).
Announcement as per Regulation 30 of the Listing Regulations
Intimation of notice sent to shareholders for transfer of shares to Investor Education and Protection Fund (IEPF)
Intimation with respect to Record Date for Payment of Dividend.
Intimation as per Regulation 30, Regulation 42 Regulation 51 of SEBI(Listing Obligation and Disclosure Requirements) Regulations, 2015.
The Company has allotted 255,615 equity shares under the Employees Stock Option Scheme (2005) and the Employees Stock Unit Scheme (2023).
Please find attached the copy of newspaper publication.
Investor presentation for the month of April 2026.
The Company has allotted 97,746 equity shares under the Employees Stock Option Scheme (2005) and the Employees Stock Unit Scheme (2023).
Please find enclosed the schedule of meeting with analyst/investor to be held on May 6, 2026.
The Company has allotted 190,760 equity shares of Rs. 10 each under the Employees Stock Option Scheme (2005).
Please find enclosed the intimation of notice sent to shareholders as per directive of Investor Education and Protection Fund Authority, Ministry of Corporate Affairs for initiation of ....
The Company has allotted 317,541 equity shares of Rs. 10 each under the Employees Stock Option Scheme (2005).
Please find attached herewith the earnings call transcript.
Please find attached herewith the copies of newspaper publication for FY2026 financial results.
The Company has allotted 209,760 equity shares of Rs. 10 each under the Employees Stock Option Scheme (2005).
Please find attached herewith certificate received from the Registrars to an Issue and Share Transfer Agent under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Please find enclosed the link for audio recordings of the Earnings Call held on April 14, 2026.
Change in Statutory Auditors of the Company.
Change in Senior Management Personnel of the Company.
Recommendation of final dividend of Rs. 1.65 per equity share of face value of Rs. 10 each, subject to the approval of the shareholders of the Company.
Please find enclosed earnings call presentation.
Annual Reports
14Credit Ratings
6Concalls
117Apr 2026
30 Apr 2026Jan 2026
31 Jan 2026Oct 2025
31 Oct 2025Aug 2025
31 Aug 2025Jul 2025
31 Jul 2025Jun 2025
30 Jun 2025May 2025
31 May 2025Mar 2025
31 Mar 2025Feb 2025
28 Feb 2025Jan 2025
31 Jan 2025Jan 2025
31 Jan 2025Dec 2024
31 Dec 2024Nov 2024
30 Nov 2024Oct 2024
31 Oct 2024Oct 2024
31 Oct 2024Sep 2024
30 Sept 2024Sep 2024
30 Sept 2024Aug 2024
31 Aug 2024Jul 2024
31 Jul 2024Jul 2024
31 Jul 2024Jun 2024
30 Jun 2024May 2024
31 May 2024Apr 2024
30 Apr 2024Apr 2024
30 Apr 2024Mar 2024
31 Mar 2024Feb 2024
29 Feb 2024Jan 2024
31 Jan 2024Jan 2024
31 Jan 2024Dec 2023
31 Dec 2023Nov 2023
30 Nov 2023Oct 2023
31 Oct 2023Oct 2023
31 Oct 2023Sep 2023
30 Sept 2023Aug 2023
31 Aug 2023Jul 2023
31 Jul 2023Jun 2023
30 Jun 2023May 2023
31 May 2023Apr 2023
30 Apr 2023Mar 2023
31 Mar 2023Feb 2023
28 Feb 2023Jan 2023
31 Jan 2023Dec 2022
31 Dec 2022Nov 2022
30 Nov 2022Oct 2022
31 Oct 2022Oct 2022
31 Oct 2022Sep 2022
30 Sept 2022Aug 2022
31 Aug 2022Jul 2022
31 Jul 2022Jul 2022
31 Jul 2022Jun 2022
30 Jun 2022May 2022
31 May 2022Apr 2022
30 Apr 2022Mar 2022
31 Mar 2022Feb 2022
28 Feb 2022Jan 2022
31 Jan 2022Jan 2022
31 Jan 2022Dec 2021
31 Dec 2021Nov 2021
30 Nov 2021Oct 2021
31 Oct 2021Oct 2021
31 Oct 2021Sep 2021
30 Sept 2021Aug 2021
31 Aug 2021Jul 2021
31 Jul 2021Jul 2021
31 Jul 2021Jun 2021
30 Jun 2021May 2021
31 May 2021Apr 2021
30 Apr 2021Mar 2021
31 Mar 2021Feb 2021
28 Feb 2021Jan 2021
31 Jan 2021Jan 2021
31 Jan 2021Dec 2020
31 Dec 2020Nov 2020
30 Nov 2020Oct 2020
31 Oct 2020Oct 2020
31 Oct 2020Sep 2020
30 Sept 2020Aug 2020
31 Aug 2020Jul 2020
31 Jul 2020Jul 2020
31 Jul 2020Jun 2020
30 Jun 2020May 2020
31 May 2020Apr 2020
30 Apr 2020Mar 2020
31 Mar 2020Feb 2020
29 Feb 2020Feb 2020
29 Feb 2020Jan 2020
31 Jan 2020Jan 2020
31 Jan 2020Dec 2019
31 Dec 2019Nov 2019
30 Nov 2019Oct 2019
31 Oct 2019Oct 2019
31 Oct 2019Sep 2019
30 Sept 2019Aug 2019
31 Aug 2019Jul 2019
31 Jul 2019Jun 2019
30 Jun 2019Jun 2019
30 Jun 2019May 2019
31 May 2019Apr 2019
30 Apr 2019Mar 2019
31 Mar 2019Feb 2019
28 Feb 2019Jan 2019
31 Jan 2019Dec 2018
31 Dec 2018Oct 2018
31 Oct 2018Aug 2018
31 Aug 2018Jul 2018
31 Jul 2018May 2018
31 May 2018Apr 2018
30 Apr 2018Feb 2018
28 Feb 2018Jan 2018
31 Jan 2018Nov 2017
30 Nov 2017Oct 2017
31 Oct 2017Jul 2017
31 Jul 2017Apr 2017
30 Apr 2017Jan 2017
31 Jan 2017Oct 2016
31 Oct 2016Held by ETFs
23 ETFs hold icicipruli · sorted by weight
Held by Mutual Funds
11 schemes hold icicipruli · sorted by weight